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ABSTRAK 
  
 Modulasi immuno kini telah menjadi bahagian yang penting dalam rawatan 
kanser, penyakit berjangkit dan kekurangan imun. Terdapat banyak tumbuhan tempatan 
di mana kompaun bioaktif boleh diekstrak. Salah satu tumbuhan herba penting yang telah 
menarik perhatian ramai penyelidik ialah Q. infectoria (manjakani). Kajian kesan ekstrak 
manjakani pada makrofaj dapat meningkatkan pengetahuan kita tentang aktiviti immuno-
modulasinya. Dalam kajian ini, makrofaj J774A.1 dirawat dengan Q. infectoria ekstrak 
manjakani dengan kepekatan 62.5, 31.25 dan 15.625 ug/ml. Proliferasi sel telah dikaji 
menggunakan ujian MTT setelah sel masing-masing dirawat dengan kepekatan ekstrak 
berbeza pada 24, 48 dan 72 jam. Selain itu, aktiviti fagositik diukur menggunakan kaedah 
cytometer dan hasilnya dianalisis selepas 72 jam rawatan. Ujian ELISA digunakan untuk 
pengesanan sitokin pada makrofaj dirawat dengan 62.5 ug/ml ekstrak manjakani. 
Proliferasi makrofaj J774A.1 bertambah dalam semua kepekatan yang dirawat berbanding 
dengan makrofaj yang tidak dirawat. Dengan cara yang sama, rawatan dengan ekstrak 
manjakani berasaskan air juga menunjukkan peningkatan dalam aktiviti fagositik 
makrofaj. Walaupun makrofaj yang dirawat dengan 62.5 ug/ml ekstrak meningkatkan 
nilai penyerapan untuk sitokin IL-2, IL-5, IL-10, IL-17A, IL-23, TGF-β dan TNF-α tetapi 
adalah tidak signifikan secara statistik daripada makrofaj yang tidak dirawat. Oleh itu, 
boleh dicadangkan bahawa ekstrak manjakani berasaskan air dapat memberi kesan kepada 
aktiviti immuno-modulasi makrofaj. Lebih banyak kajian boleh dijalankan untuk memberi 
keputusan yang lebih tepat seperti kajian DNA atau evaluasi penghasilan sitokin secara 
kuantitatif.  
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ABSTRACT 
 
 Immuno-modulatory entities have now become an important part in the 
treatment of cancer, infectious diseases and immune deficiencies. There are many local 
plants from which the bioactive compound can be extracted. One of the important herbal 
plants that attracts the attention of many researchers is Q. infectoria (manjakani). The 
effect of its gall extract on macrophages can enhance our knowledge on its immuno-
modulatory activity. In this study, macrophages J774A.1 were treated with aqueous Q. 
infectoria gall extract with a concentration of 62.5, 31.25 and 15.625 ug/ml. The 
proliferation of the cells was studied using MTT assay after treating the cells for 
respectively 24, 48 and 72 h. Apart from this, the phagocytic activity was measured using 
a flow cytometer and the results were analyzed after 72 h of treatment. Multi-analyte 
ELISArray was used in the detection of cytokines with 62.5 ug/ml treated macrophages. 
It was observed that the proliferation of J774A.1 was greater in all concentration of treated 
compared to untreated macrophages. In the same way, treatment with aqueous Q. 
infectoria extract also showed an increased in the phagocytic activity of the macrophages. 
Although treating the macrophages with 62.5 ug/ml of extract increased the absorbance 
value in IL-2, IL-5, IL-10, IL-17A, IL-23, TGF-β and TNF-α but they are not statistically 
significant from untreated macrophages. Hence it could be suggested that an aqueous Q. 
infectoria gall extract could show some effect on the immuno-modulatory activities of 
macrophages. More study can be carried out to give a detail and accurate result such as 
DNA study or quantifying the cytokine productions.  
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CHAPTER 1 
 
INTRODUCTION 
 
 Background of study 
Immune system gives protection from intruders such as bacteria, viruses or parasites and 
it has to differentiate host cells, beneficial commensal flora and those harmful invading 
organism during its activation (Male et al., 2013). Serious impairment of any arm of this 
system can cause severe or life-threatening infections in a world full of potentially 
dangerous microbes. Innate immunity always presents as ready to attack but many 
pathogenic microbes have evolved to resist the defense mechanism. The emergence of 
earliest infection by ancient disease agent, Mycobacterium tuberculosis has co-evolved 
with the human immune system by discarding and gaining genes to escape from it 
(Cambier et. al, 2014). Macrophage plays important role in avoiding defense mechanism 
as it will engulf the bacterium but not destroyed it until the host becomes immune-
compromised due to other infections such as cancer or diabetes type II to develop a 
disease.  In addition, Human immunodeficiency virus 1 (HIV-1) infected patients 
undergo altering healthy innate immune mechanisms by viruses (Howie et al., 2000). This 
condition leads to defects of innate immunity and results in a worse outcome to the patients 
with HIV-1 infection making them vulnerable to other infections. 
 
 The theory of boosting immune system now become part of modern medicine 
ranging from preventive measures, optimization of wellness or even self-medication for 
mild illnesses. Plant-derived products like polysaccharides, lectins, peptides, flavonoids 
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and tannins have been used to modulate immune response or immune system in various 
in-vitro models (Virendra Kumar et al., 2011). A medicinal plant which has an immuno-
modulatory effect could provide alternative potential substance, especially in relation to 
host defense mechanism therapy.  
 
 In 2009, the total market size for prescription and over the counter medicine 
were estimated at RM4.5 billion while the traditional medicine and health supplements 
market was estimated at RM3 billion (MOPI, 2017). Market growth has been fairly 
consistent at between 8% - 10% annually for the past several years. The process of drug 
discovery from natural products are very challenging and takes a long time to develop 
(Koehn and Carter, 2005) and taking these alternatives medication could considerably at 
risk without proper knowledge about it.  However, the increase of demands for a 
traditional supplement in Malaysia market has risen because of easy access and no 
prescription needed for traditional medicine or supplements. Natural ingredients from 
plants are suggested to have a good outcome without having extreme side effects but it 
still has a deficiency of benefit study for traditional medicine to proof its claim. 
 
 These natural ingredients could come from their leaves, stems, roots, fruits or 
seeds. One of the famous plants in traditional medicine in Malaysia exclusively in the 
treatment of women after birth is Quercus infectoria gall (known traditionally as 
manjakani). Q. infectoria gall extract have an anti-inflammatory activity that could 
suggest the immuno-modulatory activity of its properties (Kaur et al., 2004); its 
antioxidant activity and abrogates oxidative stress was claimed to induce functional 
alterations in murine macrophages (Kaur et al., 2008) and the greater amount of phenolic 
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and flavonoid contents leads to more potent antioxidant that can react with wide range of 
molecules in living cells as shown by Q. infectoria (M.Asif et al., 2012). This plant is 
demonstrated to have good benefit in treatment especially in wound healing (Umachigi 
and Jayaveera, 2008) (Chokpaisarn et al., 2017) which support the benefit of its properties 
in the immune system. 
 
 Quercus infectoria gall and medicinal uses 
Q. infectoria originates from family Fagaceae which usually known as gall oak, which is 
a small plant growing up from 4 to 6 feet tall, crooked, with smooth and bright leaves, 
acorn long and narrow, scaly and downy that prefer semi-shade to no shade or partial sun 
to full sun and requires moist soil that normally found in Greece, Asia Minor and Iran. 
They have monoecious flowers that are pollinated by wind. The galls of Q. infectoria are 
used since centuries as a home remedy to treat a sore throat and chronic diarrhea in both 
rural and urban areas (Shrestha et al., 2014). The gall can be obtained from the branches 
of the tree is called as ‘majuphal’ in India, ‘machakai’ in Kannada and ‘manjakani’ in 
Malaysia. In Malaysia ‘manjakani’ are recognized to have many benefits to the health of 
women’s intimate organs as well as to address numerous illnesses of women. One of the 
functions is to treat fungus infection and are used widely in women health after birth. 
 
Aqueous Q. infectoria gall extracts are shown to exhibit widespread antimicrobial 
activity against food-borne pathogenic bacteria (Fathabad et. al, 2015). Moreover, Q. 
infectoria is widely used in some countries such as India, Malaysia and Iran in traditional 
medicine. It is reported to contain large amounts of bioactive constituents such as 
saponins, alkaloids, tannins, glycosides, triterpenes, sterols, phenolic compounds, 
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carbohydrates, and flavonoids in various extracts (Shrestha et al., 2014). Q. infectoria has 
a high concentration of gallic and tannic acid (Kaur et al., 2008) which might be the 
foundation of natural antioxidant and antibacterial activity of its bioactive compound. 
 
 Nutgall of Q. infectoria (see Figure 1.1) comes from primarily insect gall 
induced by a wasp (Cynips sp.) on twigs of Q. infectoria (Jackson, 2014). This gall is 
excreted from its branches when the wall of the tree is being attacked by the parasite as a 
defense mechanism. The production of the galls is effective in the survival of the tree from 
cynipid wasp larvae including increased the protection against natural enemies such as 
parasitoid (Zargaran et. al, 2011). The process of fighting against parasite produce active 
compound such as gallic and tannin acid in the gall which has potential benefit as 
antibacterial and antifungal agents. The larvae will produce a hole on the surface of the 
galls when its leaves the galls. 
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Figure 1.1 Quercus infectoria gall: The galls can be identified macroscopically based on 
their physical appearances which were globular in shape and have tuberculate surface, 0.8 
cm to 2.5 cm in diameter with green-yellow in color. The galls also had an astringent smell 
and strongly pungent taste. When the larvae leave the galls it creates holes on the surface 
of the galls.  
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 Bioactive compound derived from Quercus infectoria gall 
The main constituents found in the galls of  Q. infectoria are tannin (50-70%), free gallic 
acid and ellagic acid and have high concentration of amino acids such as tannic, quinic, 
gallic, mallic and protocatechuic (Hamad et al., 2017). Tannic acid and gallic acid, are the 
important products of tannins, have been reported to have antioxidant activity (Kaur et al, 
2008) and good activity as antimicrobial (Fathabad et al., 2015), antibacterial activity (Nor 
Amilah et al., 2014), antifungal activity (Vanga et al., 2017) and anti-carcinogenic 
property (Roshni and Ramesh, 2013).  
 
 Tannin in Q. infectoria gall has bitter in taste and will make the color of the 
extract to be darker (Baharuddin et al., 2015). People commonly consume Q. infectoria 
gall by immersing it in the water. Usually, they grind the dried gall and boil it in the water 
and take it as drink beverage. Methanol solvent is best to extract the active phytochemicals 
in the Q. infectoria gall but the differences between aqueous and methanol extracts were 
insignificant (Baharuddin et al., 2015), furthermore the extracts of aqueous and acetone 
give similar results in the antimicrobial activity (Basri and Fan, 2005) thus the aqueous 
solvent are the best to replicate common user. 
 
 Water extracts of Q. infectoria also gives better yield for gallic and tannic acid 
extraction in which the concentration of both compounds are highest in water compared 
to 100% of methanol, ethanol and acetone also 70% of methanol and ethanol solvent (Ab. 
Rahman et al., 2015). By using aqueous extract, we can study the similar effect of Q. 
infectoria gall extract consumed by common people in daily life. 
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 Problems statement 
The properties of antibacterial, antifungal, anti-oxidant and anti-inflammatory by Q. 
infectoria gall have been reported by many studies but the involvement of Q. infectoria 
gall in the modulation of the immune response are still lacking.  
 
 Immune-modulators could give effect to the human system such as regulate or 
down-regulate the production of its property such as phagocytic activity, cytokines release 
and apoptotic activity in cells. By using the extract as a supplement could enhance one’s 
wellness but could also give harm to others health condition especially people with the 
immune systems impairment. Proper knowledge about the impact of its bioactive 
compound to our immune system is necessary. 
 
 Rationale of study 
Immuno-modulatory entities with additional safety and effectiveness are still in need 
especially for natural products of plant origin. It was essential to study the effect of extract 
that usually consumed by common people in daily life and to gain much knowledge about 
the characteristic of the compound in its immuno-modulatory activity. Immunotherapy for 
cancer (Khalil et al., 2016), diabetes type I (Tooley et al., 2012) and even atopic dermatitis 
problems (Nahm, 2015) are still in search for the new and future immuno-modulatory 
therapy that gives promising result in treating patients. 
 
 At present, there was only a few experimental data on the immuno-modulatory 
activity of aqueous Q. infectoria gall extract which could be used to determine the benefit 
of the extract as immuno-modulators. Q. infectoria gall extract may be used as alternatives 
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medicine to substitute current medication by reason of most immuno-stimulants and 
immuno-suppressants in clinical use are the cytotoxic drugs which can possess serious 
side effect to human. Furthermore, it is important to gain additional knowledge about its 
immuno-modulatory activity and to provide preliminary information in the understanding 
of the effectiveness of the gall extract as an agent that could possibly modulate or suppress 
the immune response in vitro prior to in vivo study.  
 
  Objectives of study 
 
1.6.1 General objectives 
 This study was conducted to evaluate the immuno-modulatory activity of            
aqueous Q. infectoria gall extract against macrophage in vitro. 
 
1.6.2 Specific objectives 
i) To access the proliferation activity of macrophage in the presence of aqueous  
Q. infectoria gall extract. 
ii) To determine the phagocytic activity of macrophages after treated with aqueous                 
Q. infectoria gall extract.  
iii) To evaluate the cytokines regulation of treated macrophages with aqueous          
Q. infectoria gall extract. 
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 Flow chart of the study 
 
  
Aqueous Q. infectoria gall 
extraction  
(conventional method)  
Cytokines assay Phagocytic assay 
Proliferation assay  
(MTT assay) 
The effect of Q. infectoria on 
murine macrophage cell line 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
 Immune system and macrophage 
Human is equipped with a complex immune system that guards and protects our body 
from infections. An immune system is alienated into two categories which are innate and 
adaptive immunity. Innate immunity gives rapid response while adaptive immunity 
provides longer protection to the infections. Innate immunity acts as the first line of host 
defense, mediated by phagocytes, able to discriminate between self and non-self and alert 
the immune response (Spiering, 2015) with several non-specific protective mechanisms 
against infection. The macrophages and neutrophils detect and attack other cells carrying 
pathogen-associated molecular patterns (PAMS) or other small proteins that signal 
pathogen invasion such as cytokines and chemokine to immediately attach to and restrict 
microbial pathogens.  
 
  Innate immunity identifies pathogen via Toll-like receptors (TLRs). TLRs that 
can be classified into cell surface TLRs and intracellular TLRs based on their localization. 
Cell surface TLRs include TLR1, TLR2, TLR4, TLR5, TLR6, and TLR10, whereas  
intracellular TLRs are localized in the endosome and include TLR3, TLR7, TLR8, TLR9, 
TLR11, TLR12, and TLR13 (Kawasaki and Kawai, 2014) that react to different and 
specific antigen pathogen-associated molecular patterns (PAMPs) such as unmethylated 
double-stranded DNA (CpG), single-stranded RNA (ssRNA), lipoproteins, 
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lipopolysaccharide (LPS), and flagellin (Lim and Staudt, 2013). In addition, acquired 
immunity eliminates pathogen in the late phase of infection and generate the 
immunological memory which characterized by specific interaction between intruders and 
host (Bonilla and Oettgen, 2010). Immune cells are being generated from bone marrow as 
hematopoietic stem cells to common granulocyte or macrophage and lymphoid 
progenitor. 
 
 Macrophages are developed directly from multicellular organisms to perform 
clearance of dying cells and protect the host by phagocytic activity through innate 
immunity (Martinez and Gordon, 2014) containing resident tissue macrophages and 
monocyte-derived recruited cells during inflammation. Disease states are conditions are 
regularly associated with macrophage activation. Macrophages are distributed into M1 
and M2 type, with typically M1 macrophages implicated in initiating and sustaining 
inflammation and M2 macrophages associated with resolution of chronic inflammation 
(Martinez et. al, 2009). M1 macrophage promotes T-helper 1 (TH1) response and has 
efficient antigen presentation capacity thus can kill intracellular pathogens and execute 
tumor destruction. On the other hand, M2 macrophage promotes TH2 response and 
responsible for clearing parasites thru encapsulation. It also regulates tumor promotion, 
tissue remodeling and immunity. 
 
 Through a process called phagocytosis, macrophages plays a very important role 
in immunological signaling, destruction or clearance of unwanted particles from tissues 
by internalization (Mutzke et al., 2015). The process begins with the binding of the 
particles to the surface of the macrophage via receptors. This lead to the establishment of 
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a phagosome and eventually to the death of the invading cell or the degradation of the 
foreign particle (Razali et al., 2014). In normal condition, macrophage will be at rest but 
could be stimulated to be active in immune response especially in phagocytosis and 
inflammation (Duque and Descoteaux, 2014). Phagocytosis activity will root to the 
inflammation at the site of infected area to enclose the infections. 
 
 Types of macrophage: for cell culture  
Murine-derived cell lines often used in a study assuming that the response of cell lines is 
suggestive to the potential response in the primary human cell (Merly and Smith, 2017). 
Murine macrophages are easy to handle in laboratory compared to human macrophage 
cell line because it does not need any differentiation step from monocytes to become 
macrophage and ready to use in any experimental design. 
 
2.2.1 J774A.1 murine macrophage 
This macrophage is derived from reticulum cell sarcoma from Mus musculus, mouse 
Strain BALB/cN. J774A.1 is a monocyte; macrophage with the morphology of a 
macrophage and mostly adherent. Most J774A.1 cells were round or elliptic shape, but the 
number of elongated and spindle-like cells slightly increased after EPS or heat-killed 
bacteria (Wu et al., 2010). In culture, J774A.1 appears as two distinct population which 
is round and monocyte-like while the other is stretched and more macrophage-like but at 
higher densities the round type is predominant but at 40-80% confluent the two population 
are highly distinct. 
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 The difference between the morphology of macrophage in low-density and high-
density culture are visualized in Figure 2.1. The cells can be distinct into a different shape, 
round and elongated (A) but most of the cells appear to be rounded (B). The cell should 
be maintained until it reaches at least 80% confluence before testing.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Morphology of macrophage (J774A.1). A: Low-density macrophage and  
B: High-density macrophage. 
 
Source: ATCC Product Sheet J774A.1 (ATCC ® TIB-67TM), (2015) 
A B 
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2.2.2 RAW 264.7 murine macrophage 
These cells are macrophage-like, Abelson murine leukemia virus-transformed cell line 
derived from BALB/c mice and suitable as a transfection host. RAW 264.7 is smaller and 
more rounded phenotype with fewer cytoplasmic extensions (Chamberlain et al., 2009), 
will pinocytose neutral red and will phagocytose latex beads and zymosan. This cell line 
is easy to propagate, high efficiency for DNA transfection, sensitivity to RNA 
interference, and supports replication of murine noroviruses. The morphology can be 
visualized in Figure 2.2. 
 
Figure 2.2 Morphology of macrophage (RAW 264.7). A: Low- density macrophage and 
B: High-density macrophage. 
 
Source: ATCC Product Sheet RAW 264.7 (ATCC® TIB71™), (2017)  
A B 
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2.2.3 THP-1 human monocytic cell line 
Human cell line THP-1 is a monocyte that derived from acute monocytic leukemia. This 
cell line is widely used to study monocyte/macrophage functions, mechanisms, signaling 
pathways, nutrient and drug transport which has become a common model to estimate 
modulation of monocyte and macrophage (Chanput et al. 2014) and also suitable to use 
as a transfection host. The morphology can be visualized in Figure 2.3. 
 
 
Figure 2.3 Morphology of monocytes (THP-1). A: Low-density monocytes and  
B: High-density monocytes 
 
Source: ATCC Product Sheet THP-1 (ATCC® TIB­202™), (2017) 
 
A B 
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 Immune system and proliferation of macrophages 
Tissue macrophage goes through in situ proliferation in a different process in order to 
increase its population density. This process is being controlled by the representative TH2 
cytokine interleukin-4 (IL-4) which a fundamental component of TH2 inflammation. 
Exogenous IL-4 was sufficient to drive the accumulation of tissue macrophages through 
self-renewal thus expansion of innate cells for pathogen control or wound repair does not 
depend on employment of potentially tissue-destructive inflammatory cells (Jenkins et al., 
2011). 
 
 The most commonly assay methods used to estimate the number of viable cells 
in multi-well plates is 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT). MTT is based on the ability of metabolically active cells to reduce the yellow 
tetrazolium salt to form insoluble purple formazan crystals, which are solubilized by the 
addition of a detergent and quantified base on color (Harizi et al., 2011). Although the 
MTT is considered to be a fast, simple and accurate in vitro method for investigation on 
the effect of different substances and nutrients, the test must be used with care because 
it’s not correlated well with actual cell growth and viability (Lü et al., 2012). It is an 
alternative to radiometric testing and is widely used in drug sensitivity or cytotoxicity 
studies. 
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 Immune system and phagocytosis 
Phagocytic removal of apoptotic cells is an important regulatory event in development, 
tissue homeostasis and inflammation during an immune response. The role of 
phagocytosis is played mostly by monocytes, macrophages, neutrophils and dendritic 
cells. Phagocytosis contributes to host defense and the pathogenesis of autoimmune, 
malignant, and metabolic disorders (Gordon, 2016).  
 
 Immune system boosts their phagocytic activity via activation of the 
macrophage. This action results in increased cell size, amplified production of lysosomal 
enzymes, enhanced cell metabolism, improved the ability to phagocytose and kill ingested 
unwanted particles such as pathogens (Fujiwara and Kobayashi, 2005). Microbes and dead 
cells could trigger inflammatory mediators to cause inflammation in the immune response. 
Therefore the host response of delivering leukocytes and plasma proteins to the site of 
infection or injury so that the offending agents could be removed or eliminated. The 
phagocytosis is equipped with lysosome which has anti-microbial substance such as 
lysozyme, nucleases, proteases, lipases and hydrogen peroxidase. 
 
 The phagocytic pathway begins when cells like macrophages engulf a solid 
particle to form an internal compartment known as a phagosome. The process of 
engulfment of solid particulate material by the macrophage occurs in a vacuole at early 
phagosome then it merges with a lysosome to form a phagolysosome. The pathogen is 
killed and digested in preparation for antigen presentation in this acidic, hydrolytic 
compartment (Aderem, 2003). The lysosome secretes different enzymes to lyse and digest 
to kill the invading microbes (see Figure 2.4) (Gordon, 2016).  
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Figure 2.4 Phagocytic pathway. A: Early phagosome, B: Phagolysosome and  
C: Lysosome. Phagocytosis is the process which a phagocyte cell engulfs a solid particle 
to form an internal compartment known as a phagosome and develop phagolysosome with 
the secretion of enzymes by lysosome. 
 
Adapted from: Gordon, (2016) 
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Q. infectoria gall extract show good anti-inflammatory in the previous study, thus support 
the activation of clearance of unwanted particles in the immune response. Flow cytometry 
analysis could be useful for detection of a wide range of particle sizes following uptake 
by macrophage in phagocytosis activity (Mutzke et al., 2015). A better understanding of 
how phagocytosis regulates immune responses will lead to the development of enhanced 
antigen-delivery tools for vaccines, new approaches for developing drugs that regulate 
inflammation and an improved understanding of how pathological inflammation develops 
during microbial infection and autoimmune diseases. 
 
  Immune system and cytokines 
There are different types of cytokines, including chemokines, interferons, interleukins, 
lymphokines and tumor necrosis factor. Cytokines are cell signaling molecules that aid 
cell to cell communication in immune responses and stimulate the movement of cells 
towards sites of inflammation, infection and trauma. In formal with other mediators, 
cytokines rule macrophages into a spectrum of inflammation-promoting “classically 
activated,” to anti-inflammatory or “alternatively activated” macrophages (Duque and 
Descoteaux, 2014).  
 
 Deregulated cytokine secretion is associated with several disease states ranging 
from chronic inflammation to allergy. During cell injury, infection, invasion, and 
inflammation; immune cells like monocytes, macrophages or non-immune cells like 
fibroblasts and endothelial cells released IL-1β (Zhang and An, 2009). Mostly, pro-
inflammatory cytokines are produced by activated macrophages and involved in the up-
regulation of inflammatory reactions.  
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 Generally the sources of inflammatory cytokines are secreted from macrophages 
(Murray and Stow, 2014), which normally act in a protective manner. However, these 
same cytokines trigger many acute and chronic inflammatory diseases. In certain infection 
cytokines play an important role to contain infection, for example, IFN- produced by 
macrophages may tolerate for a quicker response to Mycobacterium tuberculosis (MTB) 
before T-cell specific immunity develops (Robinson et al., 2010). The IFN- produced by 
macrophages may contribute greatly to effective macrophage responses that limit MTB 
growth.  
 
 Immune system and apoptosis 
Apoptosis or programmed cell death are designed to eliminate the cells via a healthy 
process in the body. On the contrary, necrosis is a premature death of cells and living 
tissue caused by external factors such as infection, toxins or trauma. Apoptotic cell death 
is considered to be a toxic process where the cell is a passive victim and follows an energy-
independent mode of death while necrosis refers to the degradative processes that occur 
after cell death thus become an inappropriate term to describe a mechanism of cell death 
(Elmore, 2007). 
  
 Cells require apoptosis to compensate for cell growth and balance the 
proliferation of new cells in the human system. In cancer, there is a loss of balance 
between cell division and cell death and cells that should have died did not receive the 
signals to do so (Wong, 2011). The problem can arise in any one step along the way of 
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apoptosis. Quantification of cell death using flow cytometry is widely used to features of 
apoptotic cells.  
 The benefit of using flow cytometry is it measures apoptosis by evaluating the 
binding of fluorescently-tagged annexin V, which is a probe for membrane 
phosphatidylserine (PS), in tandem with propidium iodide (PI) which enters cells with 
damaged membranes (Hollville and Martin, 2016). Restructuring of membrane PS early 
in apoptosis, apoptotic cells typically bind annexin V prior to PI uptake, although PI 
uptake does eventually occur during apoptosis accordingly with cells enter secondary 
necrosis. In contrast, necrotic cells typically exhibit annexin V binding and PI uptake 
simultaneously. 
 
 Immuno-modulatory and immunomodulator 
A biological or synthetic substance that could stimulate, suppress or modulate any of the 
components of the immune systems including both innate and adaptive arms of the 
immune response (Mukherjee et al., 2014). Any substances either extrinsic or intrinsic 
that have the ability to change immune response by modifying the scope, type, duration 
or competency of immune response (Lebish and Moraski, 1987) are immuno-modulators. 
In the presence of infection, cytokines will produce soluble proteins that ensure 
communication between immune and non-immune cells and will change the pathway 
from innate to adaptive immunity, thus promoting the inflammation, activating the anti-
inflammatory response or macrophage.  
 
 Studies have demonstrated that plant extracts possess various biological 
activities including antitumor and immuno-modulatory activity. Medicinal plants can be 
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a modulator that provides an alternative to conventional chemotherapy for a variety of 
diseases, especially in the condition of the immune compromised host which has impaired 
immune response or similarly in autoimmune disorders when a selective 
immunosuppression is desired (Amirghofran et al., 2009). Screening of 20 medicinal 
plants in Malaysia showed that methanolic extracts of Alpinia galangal, Orthosiphon 
aristatus and Annona muricata are able to modulate innate immune system had been 
demonstrated using CD18/11a expression and phagocytosis activity of leukocytes (Harun 
et. al, 2015). The immune-modulatory effect of a plant-derives substance can be a 
discovery of therapeutic agent for modulating the immune system. 
 
 The mechanism of immunomodulation is very complex (Figure 2.5) because it 
requires activation, proliferation and differentiation of immune response such as 
macrophage, T-helper cell, B-cell and others. Two major armies which are macrophages 
and lymphocytes have the ability to guard and activate cellular defense with the help of 
molecular detectors, such as TLRs (Spiering, 2015). Specific antibodies generated to the 
specific antigen or toxin is released to initiate the destruction of a foreign organism to 
contain the infections. 
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Figure 2.5 Mechanism of immunomodulation; antigen and antibody binding to specific 
receptor, proliferation and differentiation of immune cells with the regulations of 
cytokines or chemokines are the fundamental part in the immune system. 
 
Adapted from: Mukherjee et al., (2014) 
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 Disease associated with immune system 
Diseases associated with impairment of immune systems such as autoimmune disease like 
systemic lupus erythematous (SLE), diabetes type I, atopic dermatitis, arthritis, multiple 
sclerosis and inflammatory bowel disease become more challenging to clinicians. 
Autoimmunity conditions cause general other illnesses such as liver inflammation, kidney 
failure, and other organ deficiency. 
 
 Diabetes type I has become one of the important diseases that effects young 
people where this autoimmune disease targets the insulin secreting β cells of the pancreas 
make it lose the ability to normalize blood glucose level and other metabolites (Tooley et 
al., 2012). While in atopic dermatitis, pathogenetic mechanism of it is complex which 
related to hypersensitivity that causes by genetic abnormalities, environmental factors, 
skin barrier defects and immune dysfunction (Nahm, 2015). Meanwhile, systemic lupus 
erythematosus (SLE) that is a heterogeneous autoimmune disease that are hard to be 
identified in the early phase and involve many organs such as liver, joint and kidney (Kuhn 
et al., 2015). To diagnose this immune-related disease are very difficult and to gives 
precise treatment also very challenging. The individual immune condition differs from 
one and another and specific approach or personalized treatment is the best choices to be 
uncovered. Immunotherapy are the treatment that needs to be discovered with new and 
safe drug with low cost that could be widely available in many countries. 
 
  
  
